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A longstanding challenge in regeneration biology is to understand the role of
developmental mechanisms in restoring lost or damaged tissues and organs. As
these body structures were built during embryogenesis, it is not surprising that a
number of developmental mechanisms are also active during regeneration. However,
it remains unclear whether developmental mechanisms act similarly or differently during
regeneration as compared to development. Since regeneration is studied in the context
of mature, differentiated tissues, it is difficult to evaluate comparative studies with
developmental processes due to the latter’s highly proliferative environment. We have
taken a more direct approach to study regeneration in a developmental context
(regrowth). Xenopus laevis, the African clawed frog, is a well-established model for both
embryology and regeneration studies, especially for the eye. Xenopus eye development
is well-defined. Xenopus is also an established model for retinal and lens regeneration
studies. Previously, we demonstrated that Xenopus tailbud embryo can successfully
regrow a functional eye that is morphologically indistinguishable from an age-matched
control eye. In this study, we assessed the temporal regulation of retinal differentiation
and patterning restoration during eye regrowth. Our findings showed that during
regrowth, cellular patterning and retinal layer formation was delayed by approximately
1 day but was restored by 3 days when compared to eye development. An assessment
of the differentiation of ganglion cells, photoreceptor cells, and Müller glia indicated that
the retinal birth order generated during regrowth was consistent with that observed for
eye development. Thus, retina differentiation and patterning during regrowth is similar
to endogenous eye development. We used this eye regrowth model to assess the
role of known mechanisms in development versus regrowth. Loss-of-function studies
showed that Pax6 was required for both eye development and regrowth whereas
apoptosis was only required for regrowth. Together, these results revealed that the
mechanisms required for both development and regrowth can be distinguished from
regrowth-specific ones. Our study highlights this developmental model of eye regrowth
as a robust platform to systematically and efficiently define the molecular mechanisms
that are required for regeneration versus development.
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INTRODUCTION
Many animals have the ability to undergo regeneration, the
successful restoration of tissues and organs after injury, but
some animals lack this ability. Even though there is now
considerable knowledge regarding the cellular and molecular
pathways that regulate regeneration, the basic question of why
the same tissues and organs from diverse (or even closely related)
species often respond differently to injury and damage remains
largely unanswered. To address this question, an area of focus
has been to understand the role of developmental mechanisms
in regeneration.
As regeneration requires the restoration of lost body structures
generated during development, it is not surprising that a number
of pathways involved in development are also active during
regeneration (Schaefer et al., 1999; Lin and Slack, 2008; Malloch
et al., 2009; Martinez-De Luna et al., 2011; Halasi et al.,
2012; Meyers et al., 2012). However, it has been a challenge
to effectively identify which developmental mechanisms are
required for regeneration and to assess whether the roles of
these mechanisms are similar or different during embryogenesis
versus regeneration.
A second challenge in understanding the role of
developmental mechanisms in regeneration is that existing
models largely seek to examine regeneration in adult or mature
differentiated tissues. The mature tissues are in contrast to a
developmental environment where proliferation is high and
cellular differentiation is low or just beginning. Furthermore,
recent studies indicate that stem cells may have different
functions in developing versus adult tissues (Wang and Conboy,
2010). Thus, it remains difficult to pinpoint the developmental
mechanisms that can be successfully manipulated for inducing
adult regeneration.
To address these challenges, a model to study regenerative
mechanisms in the context of development is needed. This
approach can reduce some of the complexities in comparing
developmental processes to regenerative processes in mature
tissues. For such a model to be valuable, two important
characteristics would be needed: a high regenerative ability
coupled with well-understood developmental events. Xenopus
laevis, the South African clawed frog, fulfills these criterion
as it is an animal that is an established and well-studied
regenerative and developmental model (Beck et al., 2009; Sater
and Moody, 2017). In particular, Xenopus eye development has
been studied extensively (Perron and Harris, 1999; Rapaport,
2006; Henry et al., 2008; Viczian and Zuber, 2015). Xenopus can
also regenerate mature eye tissues including the retina and lens
[reviewed in Araki (2007), Vergara and Del Rio-Tsonis (2009),
Henry et al. (2013), Tseng (2017)]. Additional advantages of
the Xenopus system include: external development of embryos–
facilitating developmental eye studies, amenability to molecular
and cellular manipulations, and strong genetic similarity to
humans. Using Xenopus, we established an embryonic model to
study developmental eye regrowth (defined here as the ability
of an embryo to compensate for missing tissues by restoring
normal organ structures and function) (Kha and Tseng, 2018;
Kha et al., 2018).
Our recent study showed that the Xenopus tailbud embryo
at developmental stage (st.) 27 successfully regrew its eye after
significant tissue loss (Kha et al., 2018). The completion of
eye regrowth occurred by 4–5 days as overall development
progressed without delay. Importantly, the regrown eye was age
and size-appropriate with the expected complement of structures
including the lens, retina, and pigmented epithelium. It was
connected to the brain via the optic nerve and functional,
displaying visual preference. Furthermore, the function of the
regrown eye was dependent upon successful growth of new
tissues since remnant eye cells in the regrowth-inhibited eyes
lacked the ability to restore visual function (Kha and Tseng,
2018). To facilitate the use of this model to understand the
role of developmental mechanisms in regrowth, we sought to
determine whether eye formation during regrowth is comparable
to endogenous eye development. Here, we show that while
induction of regrowth delayed retinal differentiation and
patterning, the overall retinogenesis process was consistent with a
recapitulation of normal eye development. Furthermore, loss-of-
function studies using our model showed that Pax6, a gene that
is required for eye development, is also required for regrowth.
In contrast, apoptosis is not required for eye development but is
required for regrowth.
RESULTS
Restoration of Cellular Patterning
During Regrowth
In our previous study, histological analyses showed that retinal
layer formation in a regrowing eye was delayed during the first
2 days post surgery (dps) even though overall development
proceeded normally (Kha et al., 2018). The cellular patterning of
the regrowing eye during this period was more similar to embryos
at younger developmental stages. Notably, the regrowing eye
regained overall size and cellular patterning comparable to an
uninjured age-matched eye within 3–5 days post surgery (Kha
et al., 2018). To better understand eye regrowth and assess this
process as compared to normal eye development, we examined
the temporal regulation of eye formation during regrowth at three
successive 24-h timepoints.
First, we assessed the overall cellular structure and patterning
of the regrowing eye as compared to its uninjured contralateral
eye. Here, we used the contralateral eye as the control to
ensure that the comparative studies were made at the same
developmental stages. Our previous work confirmed that the
uninjured contralateral control was equivalent to the eye of age-
matched sibling embryos [(Kha et al., 2018) and data not shown].
The lens and retina of the developing eye are surrounded by
the basement membrane found in the extracellular matrix. To
examine the basement membrane structure of the embryonic
eye, a marker recognizing the basement membrane (an anti-
Laminin antibody) was used (Kha et al., 2018). At st. 34/35 in
the control embryonic eye, the basement membrane outlined the
eye cup and the lens vesicle as it proceeds through development
(Figures 1A4–6,A4’–6’). Induction of eye regrowth required
tissue removal surgery, which also disrupted the basement
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FIGURE 1 | Regrown eyes regain cellular patterning by 3 dps. Images shown are immunostained, transverse sections at three developmental timepoints
corresponding to 1, 2, and 3 days post surgery (dps). The top schematic is a diagram of a section through a mature, differentiated tadpole eye. (A,B) Regrowing
eyes display retinal patterning comparable to the contralateral control eyes (unoperated) by 3 days. White dashed lines delineate each eye. (A’,B’) Representative
images shown in panels A’ and B’ correspond to the region shown in the inset box in panel A4 for the corresponding A or B panel at high magnification. Blue color
indicates nuclear staining (TO-PRO-3). Green color indicates the basal lamina (anti-Laminin), which is expressed in all basement membranes and outlines the optic
vesicle. Magenta color indicates neural tissues (Xen1). Sample sizes: 1 day, n = 6; 2 days, n = 5; and 3 days, n = 5. (A,B, A’,B’) Up = dorsal, down = ventral, lens is
on the left. Scale bar: A,B = 100 µm and A’,B’ = 50 µm.
membrane and showed lack of laminin expression (Kha et al.,
2018). At 1 dps (st. 34/35), the basement membrane structure
was restored as it surrounded the regrowing eye entirely. Similar
to the control eye, the basement membrane surrounding the
regrowing eye was maintained through to st. 42/43 as normal size
is restored (Figures 1B4–6,B4–6’).
The Xen1 antibody recognizes neural tissues in the Xenopus
embryo and is a reliable marker for visualizing retinal layers in
the developing eye (Ruiz i Altaba, 1992; Kha et al., 2018). During
Xenopus eye development, retinal layer formation begins at st.
33/34 and is completed by st. 41 (Holt et al., 1988). Consistent
with previous studies, Xen1 expression showed that at st. 34/35,
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retinal layering was visible in the developing eye but not fully
organized. Proper patterned retinal layers are seen by st. 40/41
(Figures 1A8, A8’). In contrast, a delay is observed during
regrowth as Xen1 expression in the regrowing eye at st. 34/35
(1 dps) showed a lack of organization (Figures 1B7,B7’). By st.
40/41, the patterning in the regrowing eye is more similar to that
of a younger control eye at st. 34/35 (compare Figures 1B8,B8’
with Figures 1A7, A7’). The retinal layer patterning in the
regrowing eye was restored by 3 dps (st. 42/43) (Figures 1B9,B9’).
Together, our data indicated that the basement membrane of the
regrowing eye was fully restored by 1 dps, whereas retinal layer
formation was delayed and then restored by 3 dps.
Restoration of Retinal Differentiation
During Regrowth
The mature vertebrate retina is composed of the retinal
pigmented epithelium (RPE) and the neural retina. For Xenopus
eye development, retinal differentiation (retinogenesis) begins at
st. 24 at the ventral midline and increasingly spreads toward
the periphery along the presumptive retina (Holt et al., 1988).
The process is completed by st. 41, when the differentiated
structures found in a mature eye are present (Holt et al.,
1988). This is a short window representing an overall period
of approximately 2 days. The Xen1 expression patterns during
regrowth indicated an initial delay in differentiation (Figure 1).
We thus assessed the formation of the RPE and neural retina
during regrowth. To assess RPE differentiation, we used an
antibody against RPE65, a protein that is expressed in the
mature RPE (Yoshii et al., 2007; Vergara and Del Rio-Tsonis,
2009). During eye development at st. 34/35, RPE65 was first
expressed in a short segment extending from the ventral midline
(Figures 2A4,A4’, white dashed lines demarcate the neural retina
and lens). It was previously shown that retinal differentiation
demonstrated a dorsal bias in maturity – dorsal cells in the
central region differentiate slightly earlier than ventral ones (Holt
et al., 1988). Indeed, RPE65 expression also showed a dorsal
bias (Figure 2A4). By st. 40/41, RPE65 expression reached both
the dorsal and ventral peripheries and remained the same at st.
42/43 (Figures 2A5–6,A5’–6’). During regrowth, RPE65 showed
a similar expression pattern at 1 dps as the control (albeit
larger) eye at the same stage (compare Figures 2B4,B4’ with
Figures 2A4,A4’). This observation is consistent with our earlier
finding that the black pigment of the RPE is morphologically
visible by 1 dps in a regrowing eye (Kha et al., 2018). Unlike
a control eye, RPE65 expression in the 2 dps regrowing eye
failed to reach the periphery by st. 40/41 (compare Figure 2A5
with Figure 2B5). An additional day is required for the RPE65
expression to reach the periphery (Figure 2B6). Together, the
data indicate that RPE differentiation was delayed as compared
to the control eye. However, RPE differentiation was restored by
3 days as the embryo reached the mature eye stage (st. 42/43).
Next, we examined retinal differentiation during regrowth.
The neural retina consists of three nuclear layers and two
plexiform layers (Figure 1: schematic shows the 3 nuclear layers).
Photoreceptor cells (rods and cones) are located in the outer
nuclear layer (ONL). Bipolar, horizontal, and amacrine cells are
found in the inner nuclear layer (INL). The retinal ganglion cells
are located in the ganglion cell layer (GCL). The birth order of
retinal cell types occur in a consistent yet overlapping temporal
order with the retinal ganglion cells (RGCs) being the first to be
specified, followed by horizontal cells, cone photoreceptor cells,
rod photoreceptor cells, amacrine cells, bipolar cells, and lastly
the Müller glial cells (Wong and Rapaport, 2009). Using known
antibody markers that identify retinal cell types, we assessed the
timing of retinogenesis.
Islet1 is a marker of vertebrate RGCs including Xenopus
(Dorsky et al., 1997). The Islet1 antibody that we used also
identified additional cells in the INL including subsets of
amacrine, bipolar, and horizontal cells (Álvarez-Hernán et al.,
2013). At st. 34/35, the presumptive GCL was readily apparent
and somewhat patterned in the control eye (Figures 2A10,A10’).
At this stage, a small number of differentiated cells in the
presumptive INL showed Islet1 expression. The number of
Islet1-positive cells in the INL increased with increasing
age (Figures 2A10–12,A10’–12’). At 1 dps (st. 34/35) in
the regrowing eye, the presumptive RGC layer is apparent
but was poorly patterned and remained incomplete at
the periphery as compared to the control eye (compare
Figures 2B10,B10’ with Figures 2A10,A10’). At 2 dps (st.
40/41), the RGC layer has reached the periphery with some
Islet1-positive cells found in the INL but remained less patterned
than the same stage control (compare Figures 2B11,B11’
with Figures 2A11,A11’). At 3 dps, the Islet1 expression
pattern was largely comparable to the control eye (compare
Figures 2B12,B12’ with Figures 2A12,A12’). Together, the data
showed that retinal differentiation was delayed as compared to
the control eye. However, retinal differentiation was restored by
3 days as the embryo reached the mature eye stage (st. 42/43).
Restoration of Cone
Photoreceptor Differentiation
To further define the temporal delay in retinal differentiation
during regrowth, we used an anti-Calbindin antibody to assess
cone photoreceptor differentiation as we had done previously
(Kha et al., 2018). In Xenopus, both cone and rod photoreceptors
are generated at similar times in the middle of the retinal
differentiation sequence. However, a close study of retinogenesis
indicated that cone photoreceptors are generated just prior to
rod photoreceptors and are the 3rd cell type to be specified
(Wong and Rapaport, 2009). During eye development at st.
34/35, a few cone photoreceptor cells were detected by calbindin
expression in the central region of the presumptive photoreceptor
layer (Figures 3A4,A4’). By st. 40/41, cone photoreceptor
differentiation reached the retinal periphery and appeared to
be restored (Figures 3A5,A5’). This pattern was maintained in
st. 42/43 (Figures 3A6,A6’). In contrast, cone photoreceptors
were not observed in the regrowing eye at 1 dps (st. 34/35;
Figures 3B4,B4’). As regrowth proceeded, cone photoreceptor
differentiation was visible by 2 dps and showed patterning
that is somewhat comparable to age-matched developing eye
(compare Figures 3B5,B5’ with Figures 3A5,A5’). By 3 dps, cone
photoreceptor cells have expanded along the retina and showed
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FIGURE 2 | Regrown eyes regain retinal differentiation by 3 dps. Images shown are immunostained, transverse sections at three developmental timepoints
corresponding to 1, 2, and 3 days post surgery (dps). (A,B) The contralateral control eyes (unoperated) complete retinogenesis by st. 41. By 1 dps, RPE is already
visible in the regrowing eye as shown by anti-RPE65 signal (retinal pigmented epithelium; green). By 3 dps, Islet1 expression (identifying subpopulations of retinal
ganglion cells and subsets of amacrine cells, bipolar cells, and horizontal cells; green) show expected retinal patterning of a mature eye. White dashed lines delineate
each eye. (A’,B’) Images shown in panels A’ and B’ correspond to the region shown in the inset box in panel A4 for the corresponding (A or B) panel at high
magnification. Blue color indicates nuclear staining (TO-PRO-3). Sample sizes: 1 day, n = 5; 2 days, n = 7; and 3 days, n = 6. (A,B, A’,B’) Up = dorsal,
down = ventral, lens is on the left. Scale bar: (A,B) = 100 µm and (A’,B’) = 50 µm.
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FIGURE 3 | Regrown eyes regain cone differentiation by 3 dps. Images shown are immunostained, transverse sections at three developmental timepoints
corresponding to 1, 2, and 3 days post surgery (dps). (A,B) Differentiation of cone photoreceptor cells is delayed during 1, 2 dps but regains patterning that is
comparable to contralateral control eyes (unoperated) by 3 days. White dashed lines delineate each eye. (A’,B’) Images shown in panels A’ and B’ correspond to the
region shown in the inset box in panel A4 for the corresponding A or B panel at high magnification. Blue color indicates nuclear staining (TO-PRO-3). Green color
indicates anti-Calbindin signal (cone photoreceptors). Sample sizes: 1 day, n = 6; 2 days, n = 5; and 3 days, n = 6. (A,B, A’,B’) Up = dorsal, down = ventral, lens is
on the left. Scale bar: A,B = 100 µm and A’,B’ = 50 µm.
a comparable pattern to the control eye at st. 42/43 (compare
Figures 3B6,B6’ to Figures 3A6,A6’). Our results indicated that
in the regrowing eye, cone photoreceptor cell differentiation is
delayed by 1 day but is restored by 3 days when the embryo
reached the mature eye stage (st. 42/43).
Restoration of Rod
Photoreceptor Differentiation
To further define the temporal delay in retinal differentiation
during regrowth, we assessed rod photoreceptor differentiation
using anti-Rhodopsin antibody (Kha et al., 2018). Rod
photoreceptor cells are the fourth of seven retinal cell types
to be specified (Wong and Rapaport, 2009). At st. 34/35,
rod photoreceptor cells were first seen in a short segment
extending from the ventral midline (Figures 4A4,A4’),
reached the periphery by st. 40/41 and maintained at st.
42/43 (Figures 4A5,6,A5’,6’). In contrast, there were very few
rod photoreceptor cells seen in the ventral midline in the
regrowing eye at 1 dps (st. 34/35; Figures 4B4,B4’). This was in
contrast to the formation of GCL, which appeared to be more
advanced at the same stage (compare Figures 4B4,B4’ with
Figures 2B10,B10’). As regrowth proceeded, rod photoreceptor
differentiation expanded along the retina until it showed a similar
pattern to the control eye by st. 42/43 (compare Figures 4B6,B6’
with Figures 4A6,A6’).
To confirm our observations, we quantitated and compared
the number of rod photoreceptor cells during development and
regrowth (Figure 4C). At 1 dps, there were 28.3 ± 1.8 rod
photoreceptor cells in the control eye whereas there were only
4.2 ± 0.8 rod photoreceptor cells in the regrowing eye (n > 5
per condition and timepoint, p < 0.05). At 2 dps, the number of
rod photoreceptor cells in the control eye increased to 67.0± 2.7
whereas the number of rod photoreceptor cells in the regrowing
eye only reached 31.3 ± 3.8. By 3 dps, there were 69.6 ± 5.4
rod photoreceptor cells in the control eye whereas there was
a significant increase in the regrowing eye to 55.5 ± 5.4 rod
photoreceptor cells. Measurements of the length of the rod
differentiation zone supported the rod photoreceptor cell counts
(Figure 4D). At 2 dps, the rod differentiation zone was shorter
in the regrowing eye as compared to the control eye (n > 5 per
condition, p < 0.05). However, by 3 dps, the rod differentiation
zone in the regrowing eye reached comparable length to the
uninjured control eye (n > 6 per condition, p = 0.73). Together,
the data showed that rod photoreceptor differentiation and
patterning was delayed as compared to the control eye. However,
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FIGURE 4 | Regrown eyes regain rod differentiation by 3 dps. Images shown are immunostained, transverse sections at three developmental timepoints
corresponding to 1, 2, and 3 days post surgery (dps). (A,B) Differentiation of rod photoreceptor cells is delayed during 1, 2 dps but regains patterning that is
comparable to contralateral control eyes (unoperated) by 3 days. White dashed lines delineate each eye. (A’,B’) Images shown in panels A’ and B’ correspond to the
region shown in the inset box in panel A4 for the corresponding A or B panel at high magnification. Blue color indicates nuclear staining (TO-PRO-3). Green color
indicates anti-Rhodopsin signal (rod photoreceptors). Sample sizes: 1 day, n = 5; 2 days, n = 7; and 3 days, n = 7. (A,B, A’,B’) Up = dorsal, down = ventral, lens is on
the left. Scale bar: A,B = 100 µm and A’,B’ = 50 µm. (C) Quantification of rod photoreceptor cells in the regrowing eye structure at three developmental timepoints
corresponding to 1, 2, and 3 dps. The number of rod photoreceptors per 60 µm section in the regrown eye is comparable to number of rod photoreceptor cells in
the contralateral control eyes by 3 dps. ∗denotes p < 0.05 (n > 5 per timepoint). Data are means ± SEM. (D) Rod photoreceptor cells expression pattern was
measured and compared to the overall circumference of the retinal layer from one end of the ciliary margin zone (CMZ) to the end of the opposite CMZ in both
regrowing and contralateral eyes. The ratio of rhodopsin expression in the retinal layer over the retinal layer circumference measurements is shown. By 3 dps, the rod
photoreceptor cell expression is comparable to the contralateral control eye. ∗denotes p < 0.05 (n > 6 per timepoint). Data are means ± SEM.
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rod photoreceptor differentiation was restored by 3 days as the
embryo reached the mature eye stage (st. 42/43). Combined,
the progress of RGC differentiation at 1 dps as compared to
the initial lack of rod photoreceptor differentiation at the same
timepoint also suggested that the developmental retinal birth
order is maintained during regrowth.
Restoration of Müller Glial
Cell Differentiation
In the retina, the Müller glial cells serve as neuronal
support cells. They are typically the last retinal cell type
to be specified (Holt et al., 1988). Our data on RGC
and rod photoreceptor differentiation during regrowth were
consistent with the maintenance of the developmental retinal
birth order (Figures 2, 4). We hypothesized that if retinal
differentiation during regrowth is similar to developmental
retinal differentiation, then the cellular patterning of Müller glial
cells would be the last to be restored. To test our hypothesis,
we used a Müller glial cell marker, an anti-glutamine synthetase
antibody, to assess its differentiation pattern as we did previously
(Kha et al., 2018). As expected for a cell type that is the last to be
specified during retinogenesis, there was no detectable glutamine
synthetase expression indicative of Müller glial differentiation
in the control eye at st. 34/35 (Figures 5A5,A5’). The presence
of Müller glial cell patterning was visible by st. 40/41 and full
patterning was observed by st. 42/43 (Figures 5A6,7,A6’,7’).
In the regrowing eye, there was also no detectable Müller
glial differentiation at st. 34/35 (Figures 5B5,B5’). By 2 dps
(st. 40/41), only a small number of Müller glial cells were
visible – much less when compared to the control eye (compare
Figures 5B6,B6’ with Figures 5A6,A6’). By 3 dps (st. 42/43), the
pattern in the regrowing eye was similar to that of the pattern
observed for st. 40/41 control eye (compare Figures 5B7,B7’ with
Figures 5A6,A6’). Müller glial differentiation was restored by st.
45/46 at 4 dps (Figures 5B8, B8’). Together, the data showed
that Müller glial differentiation was delayed as compared to the
control eye. However, Müller glial differentiation was restored
by 4 days – a timepoint that was later than the restoration of
patterning observed for other retinal cell types. These findings
supported the hypothesis that Müller glial cells are specified later
than other retinal cell types in the regrowing eye.
Changes in Pax6 Expression
During Regrowth
Pax6 is an eye field transcription factor that is expressed in
the presumptive eye primordium after gastrulation (st. 12.5)
and specifies the eye field (Zuber et al., 2003). Prior to st.
33/34, Pax6 mRNA is expressed throughout the neural retina
(Hirsch and Harris, 1997). By st. 33/34 and onward, Pax6 mRNA
expression becomes more restricted to the presumptive GCL and
INL of the retina so that by st. 42, Pax6 expression is observed
only in those two layers (Hirsch and Harris, 1997). We used
an anti-Pax6 antibody to assess its expression during regrowth
(Rungger-Brändle et al., 2010). Consistent with previous reports,
we observed that Pax6 expression in the control eye was mostly
restricted to the presumptive GCL and INL and extended out
to the periphery at st. 34/35 (Figures 6A4,A4’). By st. 40/41,
Pax6 expression was tightly restricted to the GCL and INL
(Figures 6A5,A5’) and retained this expression pattern through
st. 42/43 (Figures 6A6,A6’). In the 1 dps regrowing eye, the
retinal layers were not apparent (as seen by Xen1 expression,
Figure 1B7). At this timepoint, Pax6 expression was not localized
and remained expanded, with apparent higher expression levels
in the central region (Figures 6B4,B4’). This pattern was more
reminiscent of Pax6 expression in embryos younger than st.
33 (Hirsch and Harris, 1997). By 2 dps (st. 40/41), Pax6 was
largely restricted to the GCL and INL in the regrowing eye
although expression near the retinal periphery is weaker than
those cells located more centrally (Figures 6B5,B5’). By 3 dps,
Pax6 patterning was restored as its expression became restricted
to GCL and INL (Figures 5B6,B6’). Together, our data indicated
that Pax6 expression was not restricted to the GCL and INL layers
1 dps in the regrowing eye. As regrowth continues, these Pax6-
expressing cells changed and became restricted to the GCL and
INL of the retina by 3 dps.
Assessment of the Roles of Pax6 and
Apoptosis During Development
and Regrowth
A key feature of this developmental eye repair model is that it
can facilitate a rapid assessment of development and regenerative
mechanisms. Our previous work and current data combined
suggest that eye formation and differentiation during regrowth is
delayed but largely followed the normal developmental process,
resulting in an eye that was indistinguishable to a normal
one (Figures 1–6; Kha et al., 2018). This model now provides
the opportunity to use the same developmental context to
ask whether specific molecular mechanisms are required in
development and/or regeneration for the eye. Therefore, we
assessed the roles of Pax6 (which is required for eye development)
and apoptosis (which is required for eye regrowth) in both eye
development and regrowth.
Pax6 is required for proper vertebrate eye development. In
Xenopus tropicalis, loss-of-function Pax6 mutations reduced eye
size and shows additional eye defects (Nakayama et al., 2015).
X. laevis embryos injected with a Pax6 morpholino showed
reduced or absent eyes (Rungger-Brändle et al., 2010). We also
examined Pax6 loss-of-function effects on the eye. We injected
either a published Pax6 morpholino or a control morpholino
into the dorsal blastomere at the 4-cell stage and assessed for
eye defects at a tadpole stage (st. 46). Consistent with previous
studies, Pax6 morpholino expression resulted in eye defects
in the majority of embryos (57.1%, n = 91) as compared to
embryos expressing a control morpholino (0%, n = 30, p < 0.05)
(Figure 7A). The eye defects included reduced or absent eyes
(Figure 7C, compare top panels).
In X. laevis, apoptosis can be detected in embryos starting
at gastrulation (st. 10.5) and was observed in the anterior
region throughout neurulation (Hensey and Gautier, 1998).
For apoptosis inhibition during development, we used M50054,
a known apoptosis inhibitor that blocks caspase activity and
successfully inhibited both Xenopus tadpole tail regeneration
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FIGURE 5 | Regrown eyes regain Müller glia differentiation by 4 dps. Images shown are immunostained, transverse sections at four developmental timepoints
corresponding to 1, 2, 3, and 4 days post surgery (dps). (A,B) Regrown eyes show differentiation of Müller glial cells beginning at 2 dps. However, proper patterning
of Müller glial cells is delayed in the regrowing eyes when compared to the contralateral control eyes until 4 dps. White dashed lines delineate each eye. (A’,B’)
Images shown in panels A’ and B’ correspond to the region shown in the inset box in panel A5 for the corresponding A or B panel at high magnification. Blue color
indicates nuclear staining (TO-PRO-3). Green color indicates anti-Glutamine Synthetase (identifies Müller glial). Sample sizes: 1 day, n = 5; 2 days, n = 5; and 3 days,
n = 5. (A,B, A’,B’) Up = dorsal, down = ventral, lens is on the left. Scale bar: A,B = 100 µm and A’-B’ = 50 µm.
and eye regrowth (Tsuda et al., 2001, Tseng et al., 2007;
Kha et al., 2018). Embryos were treated with 28 µM of M50054
from st. 10 (gastrulation) to st. 27 (tailbud embryo) and
scored at st. 46 (tadpole). Embryos treated with either M50054
(n = 30) or DMSO (vehicle only, n = 30), did not display
any morphological eye defects (Figures 7A,C, compare bottom
panels). Our previous study also showed that M50054 treatment
from st. 27 to st. 34/35 did not induce eye defects (Kha et al.,
2018). These data were also consistent with a previous study
showing that overexpression of the anti-apoptotic gene, BcL-
xL, during embryogenesis did not induce eye defects (Johnston
et al., 2005). Thus, apoptosis does not appear to be required for
eye development.
To assess the role of Pax6 in eye regrowth, the same
Pax6 morpholino injection was carried out using a reduced
concentration so as to enable normal overall development. This
is to ensure that eye tissue removal surgery can be performed
on embryos with normal eyes. 81.8% of embryos expressing
the control morpholino in the eye region at st. 27 fully regrew
eyes (Figure 7B, RI = 278, n = 22; and Figure 7D, compare
top panels). In contrast, only 13.7% of embryos expressing the
Pax6 morpholino in the eye region at st. 27 showed full eye
regrowth whereas 86.3% failed (Figure 7B, RI = 168, n = 51,
p < 0.01 when compared to control; and Figure 7D compare
top panels). Thus, Pax6 morpholino successfully blocked eye
regrowth. For apoptosis, we confirmed our previous study
showing that inhibition of apoptosis using M50054 blocked eye
regrowth [Figure 7B, n = 41, p < 0.01, and Figure 7D; compare
bottom panels, and (Kha et al., 2018)]. Our data indicate that Pax6
is required for successful Xenopus eye regrowth. Although this is
not an unexpected result, this data showed that at least one key
eye development gene is used for eye regrowth.
DISCUSSION
In this study, we showed that eye formation during regrowth
was delayed but generally followed the endogenous retinal
differentiation and cellular patterning process to generate a
regrown eye that is age and size appropriate (summarized in
Figure 8A). Consistent with this data, the formation of the ciliary
margin zone (CMZ) was also delayed. The CMZ is located at the
periphery of the retina and produces all retinal cell types for eye
growth post-embryonically (Hollyfield, 1971). It can be visualized
by its distinct spatial cellular organization in eye sections and
was formed by st. 34/34 (Supplementary Figures S1A,A’). In the
regrowing eye, the formation of the CMZ was delayed until st.
40/41 (2 dps; Supplementary Figures S1B,B’).
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FIGURE 6 | Regrown eyes regain Pax6 patterning by 3 dps. Images shown are immunostained, transverse sections at three developmental timepoints
corresponding to 1, 2, and 3 days post surgery (dps). (A,B) Pax6 expression in the regrowing eye is less organized at 1 dps but regains patterning similar to
contralateral control eyes (unoperated) by 3 dps. White dashed lines delineate each regrowing eye. (A’,B’) Images shown in panels A’ and B’ correspond to the
region shown in the inset box in panel A4 for the corresponding A or B panel at high magnification. Blue color indicates nuclear staining (TO-PRO-3). Green color
indicates anti-Pax6 signal. Sample sizes: 1 day, n = 5; 2 days, n = 7; and 3 days, n = 6. (A,B, A’,B’) Up = dorsal, down = ventral, lens is on the left. Scale bar:
A,B = 100 µm and A’,B’ = 50 µm.
A distinct characteristic of retinogenesis is that it contains
an intrinsic timer for initiating differentiation. In X. laevis,
retinogenesis timing remained the same and began by st. 24 even
when there was a significant reduction of retinal progenitors cells
by chemical inhibition of proliferation during embryogenesis
(Harris and Hartenstein, 1991). In our eye regrowth model,
a significant reduction of retinal progenitors (average loss is
approximately 83%) is achieved by tissue removal surgery at
st. 27 (Kha et al., 2018). Here, we examined the temporal
regulation of the regrowth process in more detail. Endogenous
retinogenesis is initiated at st. 24 and completes by st. 41, a
time period of about 2 days (Holt et al., 1988). Our previous
work showed there was a significant increase in proliferation
at the injury site during the first 24 h of regrowth (Kha et al.,
2018). Here, we report that reparative retinogenesis showed a
delay and started at 1 dps (st. 34/35) with completion occurring
by 3 dps (st. 42/43). Like the endogenous process, reparative
retinogenesis needed a time period of about 2 days. These
results suggest that while retinogenesis can be re-induced at a
developmental stage later than st. 24, the overall time required
to complete the differentiation process was maintained as for
development. Even though the eye formation time window
can be re-started past the endogenous timeframe, there was
no shortening of the eye formation period to catch up as
quickly as possible.
As the first differentiated retinal cells are generated starting
at st. 24, there is a continual decrease in the mitotic index
of the retinal progenitor cells (RPCs) until most cells have
exited the cell cycle by st. 37/38 (Holt et al., 1988). During
this time, the estimated cell doubling time increases from 8.6
to 56 h (Rapaport, 2006). In contrast, there is significantly
increased mitotic activity in the first 24 h during eye regrowth
that continues until the regrown eye reached the expected age-
appropriate size by 3 dps (Kha et al., 2018). The proliferative burst
of RPCs in eye regrowth is counter to the endogenous process
at the same developmental stages where cells are becoming
postmitotic. Moreover, the increase in RPC proliferation,
coupled with the delay of retinal differentiation suggests that
induction of regrowth temporarily inhibited retinogenesis. There
is no specific cell number required for retinogenesis as the
initiation of Xenopus retinogenesis is not affected by greatly
reduced retinal cell divisions during embryogenesis (Harris
and Hartenstein, 1991). One possibility is that the sudden
loss of RPCs at st. 27 via tissue removal surgery triggers
a signal that extends the stem cell multipotency of RPCs
in order to restore normal size. (It is also possible that
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FIGURE 7 | Development and regrowth require Pax6, but only regrowth requires apoptosis. (A) Comparison of developmental eye defects percentage from embryos
injected at the 4-cell stage (1 blastomere) with either the control or Pax6 morpholino or treated with DMSO control or M50054 at st. 10. A zero denotes no abnormal
phenotype in the control by st. 27. ∗denotes p < 0.05 (n > 90). Data are means ± SEM. (B) Graphical representation of tadpoles achieving full eye regrowth at 5 dps
(st. 46) with morpholino injection or apoptosis inhibitor treatment. ∗∗denotes p < 0.01 (n > 20). Data are means ± SEM. (C,D) Comparison of requirements for eye
development and regrowth. (C) Pax6 morpholino injected tadpoles show reduced eyes when compared to the control by st. 46 in development. Apoptosis inhibitor
show no effect on eye development (n > 30 per condition). Closed yellow arrowhead indicates eye of control, untreated tadpole. Open yellow arrowhead indicates
eye of treated tadpole. (D) Pax6 morpholino and apoptosis inhibitor affects eye regrowth (n > 30). Closed yellow arrowhead indicates the eye of a control, untreated
tadpole. Open yellow arrowhead indicates the eye of an inhibitor treated tadpole. (C,D) Up = anterior, down = posterior. Scale bar: C,D = 500 µm.
the source cells may be non-retinal in origin.) Although we
used Pax6 as a differentiation marker in this study, it is
also required for maintaining the multipotent state of RPCs
prior to retinogenesis (Marquardt et al., 2001). The absence
of restricted Pax6 expression in the regrowing eye at 1 dps
(compare Figures 6B4,A4) is reminiscent of its expression at the
younger, proliferative, developmental stages (Hirsch and Harris,
1997). It will be highly informative to identify the molecular
mechanisms that regulate RPC proliferation during regrowth as
this model has the potential to become a useful system to study
endogenous RPC expansion.
During eye regrowth (st. 27 to st. 42/43), the embryo
is changing rapidly as it proceeds from being a tailbud
embryo with unformed organs toward becoming a tadpole with
differentiated body structures (Nieuwkoop and Faber, 1994).
Once eye regrowth is initiated after tissue loss, it appears to
follow the endogenous developmental program and remain
unaffected by rapid changes in the surrounding tissues during
development. Indeed, the overall retinal birth order that was
observed for the cell types examined was consistent with the
described order for Xenopus retinogenesis. Of note, our study
of retinal differentiation during regrowth did not specifically
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examine each individual retinal cell type that is generated
during eye formation. It is possible that there may exist some
differences in formation of the regrown eye as compared to
eye development that was not detected by the retinal markers
used in this study.
Our findings revealed that successful eye development
during regrowth induced similar cellular events as for eye
development. This model now provides the opportunity to
directly examine the role of developmental mechanisms in
eye regrowth. We used this model to compare the role of
two mechanisms, Pax6 and apoptosis, in development and
regrowth (summarized in Figure 8B). Given the role of
Pax6 as a “master regulator” of eye formation, it was not
surprising that Pax6 was found to be also required for eye
regrowth. In contrast, we found that apoptosis appears to be
a regrowth-specific mechanism. Thus we have successfully
used this model to define an initial similarity and an initial
difference between eye development and regrowth. As there
is a wealth of knowledge on the role of Pax6 (and other
known regulators) during eye development, it will be highly
feasible to distinguish any differences in the function of
Pax6 and other genes in regrowth. For further comparison
to developmental eye regrowth, follow-up studies can
FIGURE 8 | Summary. (A) A summary of retinal cell differentiation during
regrowth as compared to development. The stages correspond to 1, 2, 3,
and 4 days post surgery (dps), respectively. (B) Summary of required
processes identified in eye development and regrowth.
then be performed to examine the role of these genes in
tadpole and adult retinal regeneration using established
Xenopus models (Yoshii et al., 2007; Vergara and Del
Rio-Tsonis, 2009; Araki, 2014). Potentially, developmental
mechanisms that are not required for eye regrowth can also
be identified. In summary, this developmental eye regrowth
model will serve as a robust platform for systematically
examining the common view that regeneration is a
recapitulation of development.
MATERIALS AND METHODS
Embryo Culture and Surgery
Embryos were obtained via in vitro fertilization and raised in
0.1× Marc’s Modified Ringer (MMR: 1 mM MgSO4, 2.0 mM
KCl, 2 mM CaCl2, 0.1 M NaCl, 5 mM HEPES, pH 7.8)
medium (Sive et al., 2000). The eye removal surgery and the
regrowth assay were performed as described previously (Kha
et al., 2018). Embryos at stage (st.) 27 (Nieuwkoop and Faber,
1994) were anesthetized with MS222 (Sigma) prior to surgery.
Surgery was performed using fine surgical forceps (Dumont
No. 5). An initial cut is first made in the skin surrounding
the protruding eye cup and overlying lens placode. The cut is
continued around the raised outline of the eye and the protruding
tissues are removed. After surgery, embryos were transferred
into 0.1× MMR, allowed to recover, and then cultured at
22◦C for 1–5 days.
Embryo Sectioning and
Immunofluorescence Microscopy
For agarose embedding and sectioning, animals were fixed
overnight at 4◦C in MEMFA (100 mM MOPS (pH 7.4), 2 mM
EGTA, 1 mM MgSO4, 3.7% (v/v) formaldehyde) (Sive et al.,
2000) and processed according to Kha et al. (2018). Embryos
and tadpoles were embedded in 4–6% low-melt agarose and
sectioned into 60 µm slices using a Leica vt1000s vibratome.
Sections were stained with primary antibodies including: Xen1
(pan-neural antibody, clone 3B1, 1:50 dilution, Developmental
Studies Hybridoma Bank, RRID: AB_531871), anti-Islet1
(retinal ganglion cells and inner nuclear cell layer, clone
40.2D6, 1:200 dilution, Developmental Studies Hybridoma
Bank, RRID: AB_528315), anti-Glutamine Synthetase (Müller
glia, 1:200 dilution, Sigma-Aldrich, RRID: AB_259853),
anti-Laminin (basal lamina, 1:300 dilution, Sigma-Aldrich,
RRID: AB_477163), anti-Rhodopsin (rod photoreceptor
cells, clone 4D2, 1:200 dilution, EMD Millipore, RRID:
AB_10807045), anti-Calbindin-D-28 K (cone photoreceptor
cells, 1:500 dilution, Millipore Sigma, RRID: AB_258818),
anti-Pax6 (clone Poly19013, 1:500 dilution, BioLegend, RRID:
AB_291612), anti-RPE65 (retinal pigment epithelium, 1:500
dilution, ThermoFisher Scientific, RRID: AB_2181003). Alexa
fluor conjugated secondary antibodies were used at 1:1000
dilution (ThermoFisher Scientific). TO-PRO-3 (Molecular
Probes) was used for DNA staining. The contralateral eye was
used as the control. For each timepoint, at least 5 embryos
were analyzed. In all embryos examined, the observed cellular
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patterns were consistent for each antibody that was used.
Quantification of rod photoreceptor cell numbers was performed
using sections stained with an anti-Rhodopsin antibody. The
number of rod photoreceptor cells was counted per 60 µm
sections (n > 5 per timepoint). Rod photoreceptor cells
expression pattern was measured in pixels as a drawn line
along the outer nuclear layer and compared to the overall
circumference of the retinal layer from one end of the ciliary
margin zone (CMZ) to the other end of the CMZ (n > 5 per
timepoint). The ratio of rhodopsin expression in the retinal
layer over corresponding the retinal layer circumference
measurement was calculated.
Microscopy
A Nikon A1R confocal laser scanning microscope (UNLV
Confocal and Biological Imaging Core) was used to image
immunostained tissue sections. Images of whole animals were
obtained using a ZEISS SteREO Discovery V20 microscope with
an AxioCam MRc camera. ZEN Image Analysis software and/or
the open-source FIJI imaging software (Schindelin et al., 2012)
were used to analyze and/or process all acquired images.
Chemical Treatments and
Morpholino Injections
For apoptosis inhibition, embryos were treated with 28 µM
of M50054 (Millipore, EMD Biosciences, Burlington, MA,
United States, CAS number 54135-60-3). For vehicle control,
dimethyl sulfoxide (DMSO) was used at the same concentration
as for M50054 treatment (0.1%). For the developmental assay,
age-matched embryos were raised in 0.1× MMR medium
containing the inhibitor starting at st. 10 until st. 27. Eye
development was assayed by st. 46. To assay for regrowth, eye
surgery was performed on st. 27 tailbud embryos. The embryos
were allowed to briefly recover, and then transferred into 0.1×
MMR medium containing the inhibitor. After 1 day, embryos
were washed with two changes of 0.1×MMR. Eye regrowth was
assayed between 1 and 5 days post-surgery.
For morpholino injections, the following morpholinos
(MO) were purchased from Gene Tools LLC (Philomath,
Oregon): Pax6MO: 5′-GCTGTGACTGTTCTGCATGTCGAG-
3′ (Li et al., 1997; Rungger-Brändle et al., 2010);
and the non-specific standard control oligomer: 5′-
CCTCTTACCTCAGTTACAATTTATA-3′. Each morpholino
was modified with 3′ fluorescein. Morpholinos were
resuspended in sterile water to a concentration of 1 mM.
For both developmental and regrowth studies, morpholinos
were injected separately into a dorsal blastomere of a 4-
cell embryo using a microinjector (Harvard Apparatus,
Holliston, MA)– targeting only one side of the embryo.
Embryos with fluorescent signal in the eye region were selected
for further analysis. A previously published concentration
of 30 ng/embryo (Rungger-Brändle et al., 2010) was used
for verification of published phenotypes. The titrated
dosages for morpholino injections were: 27 ng/embryo
(developmental assay) and 15 ng/embryo (eye regrowth
assay). Lethality was observed in st. 27 tailbud embryos
that were injected with 35.7 ng of Pax6 morpholino at
the 4-cell stage.
Assessment of Eye Regrowth
The regrowth of the operated eyes as compared to unoperated
contralateral eyes was assessed using the Regrowth Index (RI)
as previously described (Kha et al., 2018). The quality of eye
regrowth was scored based on 4 phenotype categories: full,
good, weak, and none. Full, RI = 300; Partial, RI = 200; Weak,
RI = 100; None, RI = 0. The RI ranges from 0 to 300, where 0
indicates no eye regrowth of all embryos in a given condition,
100 if all embryos achieve weak regrowth, 200 if all embryos
achieve good regrowth, and 300 indicates that all embryos achieve
full regrowth. Raw data from scoring was used to compare
eye regrowth experiments. The unoperated contralateral eyes of
embryos showed no difference from unoperated control eye of
age-matched sibling embryos.
Statistical Analysis
To compare eye regrowth, raw data from scoring was used.
Comparison of two treatments was analyzed with Mann-
Whitney U test for ordinal data with tied ranks, using normal
approximation for large sample sizes. Multiple treatments were
compared using a Kruskal-Wallis test, with Dunn’s Q corrected
for tied ranks. All other experiments were analyzed using a
Student’s t-test.
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